ScreenerHero

IBT-B Infant Bacterial Therapeutics AB (publ)

STO · SE · Healthcare · Biotechnology · ibtherapeutics.com
69.80SEK+1.16%Mkt Cap: 89.94M $P/E: —

Infant Bacterial Therapeutics AB (publ) operates as a clinical stage pharmaceutical company develops and markets drugs to prevent serious neonatal diseases affecting premature infants in Sweden. The company's lead drug c…

Industry Peers

Biotechnology
Screen all
VRTX
Vertex Pharmaceuticals Incorporated
$127.24BUSDP/E 29.3
REGN
Regeneron Pharmaceuticals, Inc.
$76.05BUSDP/E 18.3
MRNA
Moderna, Inc.
$74.84BUSD
ARGX
argenx SE
$56.77BUSDP/E 37.1
ARGX
argenx SE
$58.21BUSDP/E 35.5
UCB
UCB SA
$41.93BUSDP/E 17.9
RVMD
Revolution Medicines, Inc.
$42.84BUSD
ONC
BeOne Medicines AG
$41.27BUSDP/E 64.9
RPRX
Royalty Pharma plc
$32.61BUSDP/E 30.0
ALNY
Alnylam Pharmaceuticals, Inc.
$29.97BUSDP/E 37.8
ROIV
Roivant Sciences Ltd.
$25.66BUSD
BNTX
BioNTech SE
$24.05BUSD
GMAB
Genmab A/S
$23.24BUSDP/E 29.8
INSM
Insmed Incorporated
$22.98BUSD
GMAB
Genmab A/S
$22.23BUSDP/E 30.6
INCY
Incyte Corporation
$22.85BUSDP/E 14.4
JAZZ
Jazz Pharmaceuticals plc
$15.02BUSDP/E 15.9
ASND
Ascendis Pharma A/S
$14.87BUSDP/E 17.3
EXEL
Exelixis, Inc.
$14.45BUSDP/E 18.4
SMMT
Summit Therapeutics Inc.
$13.81BUSD

Key Statistics

Company
Market Cap89.94M USD
Enterprise Value79.17M USD
Revenue (TTM)—
Gross Profit—
Net Income (TTM)-6.23M USD
Revenue/Share—
Last Price69.80 SEK
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees6
CountrySE
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG—
EV/EBITDA—
EV/Revenue—
P/S—
P/B17.66
EPS (TTM)-6.09
EPS (Forward)—
52W Range
43.2581% of range76.10
52W High76.10 SEK
52W Low43.25 SEK
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-61.87%
ROA-40.29%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-6.92M USD
CapEx (TTM)—
FCF Margin—
FCF Yield-4.14%
Net Debt-10.39M USD
Net Debt/EBITDA—
Balance Sheet
Debt/Equity—
Current Ratio1.67
Quick Ratio1.66
Book Value/Sh3.94 SEK
Cash/Share8.06 SEK
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 SEK
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.13.02M
Float11.23M
Insiders14.52%
Institutions36.80%
Technical
SMA 5066.01 (+5.7%)
SMA 20057.59 (+21.2%)
Beta0.35
S&P 52W Chg14.58%
Avg Vol (30d)8.92K
Avg Vol (10d)6.85K
Technical Indicators
RSI (14)58.9
MACD1.2034
MACD Signal0.9539
MACD Hist.+0.2495
BB Upper71.91 SEK
BB Middle67.22 SEK
BB Lower62.54 SEK
BB Width13.92%
ATR (14)3.474 SEK
Vol Ratio (20d)0.73x